E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/21/2023 in the Prospect News Convertibles Daily and Prospect News Liability Management Daily.

Silicon Labs details conversion, redemption for 0.625% notes due 2025

By William Gullotti

Buffalo, N.Y., June 21 – Silicon Laboratories Inc. reported converting the majority of its 0.625% convertible senior notes due 2025 ahead of its June 20 par call, according to an 8-K filing with the Securities and Exchange Commission.

As previously reported, holders were entitled to redeem their convertibles into shares of the company’s common stock at a rate of 8.198 shares per $1,000 principal amount, which is equivalent to a conversion price of $121.98 per share.

Holders converting prior to the June 16 conversion deadline also received an additional 0.4101 shares per $1,000 principal amount, as called for by the June 1, 2020 indenture. The company planned to settle the conversions with a combination of shares plus cash in lieu of any fractional shares.

As of the conversion deadline, Silicon Labs received conversion notices from the holders of 99.74% of the notes, representing $533.6 million outstanding principal amount. As a result, the company paid $533.6 million in cash and issued 919,897 shares of common stock to the converting holders, as well as $47,000 in lieu of fractional shares.

The remaining $1.4 million outstanding principal amount was redeemed at par plus accrued interest.

Silicon Labs is an Austin, Tex.-based semiconductor company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.